COVID-19 Spike Protein PharmaGenie ELISA Kit (SBRS1712)

The Assay Genie PharmaGenie ELISA Kit supports quantitative detection of the SARS-CoV-2 Spike protein, enabling vaccine development, antiviral screening, and serological research workflows. The kit works with cell culture supernatants and serum samples, using a colorimetric readout compatible with standard microplate readers. Each kit contains reagents for 96 assays, supplying enough material for full-plate experimental runs or multiple smaller studies. Researchers studying viral entry mechanisms, antibody responses, or therapeutic candidates can measure Spike protein levels across infection models and immunization studies. The kit format supports in vitro research applications and integrates into standard immunology and virology laboratory protocols.